| 标题 |
Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical and Translational Medicine 作者:Longgang Wang; Bing Liu; Luguang Liu; Liqing Liu; Rong Li; et al 出版日期:2026-05-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)